A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention.
Biomarkers may be used alone or in combination to assess the health or disease state of an individual.
Researchers at the Cancer Institute (WIA) have identified a panel of five protein markers in the blood that can help with an early diagnosis of a common and lethal form of ovarian cancer.
Combination of five markers - CA125, IGFBP2, SPP1, TSP1 and ADI were used for the study.